Cargando…
Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery
While the inhalation route has been used for millennia for pharmacologic effect, the biological barriers to treating lung disease created real challenges for the pharmaceutical industry until sophisticated device and formulation technologies emerged over the past fifty years. There are now several i...
Autores principales: | Plaunt, Adam J., Nguyen, Tam L., Corboz, Michel R., Malinin, Vladimir S., Cipolla, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880668/ https://www.ncbi.nlm.nih.gov/pubmed/35214039 http://dx.doi.org/10.3390/pharmaceutics14020302 |
Ejemplares similares
-
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
por: Plaunt, Adam J., et al.
Publicado: (2021) -
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021) -
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
por: Hersh, David S., et al.
Publicado: (2016) -
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
por: Waheed, Saquib, et al.
Publicado: (2022) -
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)